Daniel Sliz

Summary

Publications

  1. doi request reprint Standards of statin usage in Poland in high-risk patients: 3ST-POL study results
    Daniel Sliz
    Medical University of Warsaw
    Kardiol Pol 71:253-9. 2013
  2. ncbi request reprint 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines
    Daniel Sliz
    3rd Department of Internal Diseases and Cardiology, Medical University of Warsaw, Warszawa, Poland
    Pol Arch Med Wewn 120:328-33. 2010

Detail Information

Publications2

  1. doi request reprint Standards of statin usage in Poland in high-risk patients: 3ST-POL study results
    Daniel Sliz
    Medical University of Warsaw
    Kardiol Pol 71:253-9. 2013
    ..According to epidemiological studies, dyslipidaemia is the commonest risk factor of atherosclerosis in the Polish population. It is estimated that 18 million adult Poles are affected by dyslipidaemia...
  2. ncbi request reprint 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines
    Daniel Sliz
    3rd Department of Internal Diseases and Cardiology, Medical University of Warsaw, Warszawa, Poland
    Pol Arch Med Wewn 120:328-33. 2010
    ..For the patient, as the beneficiary of an effective pharmacotherapy, it is of utmost importance that his or her physician can take maximum advantage of the whole potential of the available medications...